pI: 6.6086 |
Length (AA): 299 |
MW (Da): 33648 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
40 | 279 | 4kkd (B) | 448 | 660 | 32.00 | 0 | 1 | 0.814369 | 1.41 |
42 | 108 | 2qy0 (B) | 447 | 510 | 33.00 | 0 | 0.31 | 0.305532 | 1.46 |
42 | 88 | 2pka (A) | 16 | 58 | 45.00 | 0.0001 | 0.81 | 0.372718 | 1.36 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_166843)
Species | Accession | Gene Product |
---|---|---|
Echinococcus granulosus | EgrG_001046200 | subfamily S1A unassigned peptidase S01 family |
Echinococcus multilocularis | EmuJ_001046200 | subfamily S1A unassigned peptidase (S01 family) |
Schistosoma japonicum | Sjp_0206470 | Enteropeptidase precursor, putative |
Schistosoma japonicum | Sjp_0025910 | Transmembrane protease, serine 9, putative |
Schistosoma mansoni | Smp_112530 | hypothetical protein |
Schistosoma mansoni | Smp_194090 | subfamily S1A unassigned peptidase (S01 family) |
Schistosoma mansoni | Smp_174530 | aminopeptidase PILS (M01 family) |
Schmidtea mediterranea | mk4.019014.00 | |
Schmidtea mediterranea | mk4.000032.30 | |
Schmidtea mediterranea | mk4.000567.07 | Subfamily S1A unassigned peptidase |
Schmidtea mediterranea | mk4.015032.02 | |
Schmidtea mediterranea | mk4.005543.00 | |
Schmidtea mediterranea | mk4.001890.04 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Bos taurus | Trypsin I | 246 aa | 23.6% | 250 aa | Compounds | References |
Oryctolagus cuniculus | Thrombin | 235 aa | 25.0% | 212 aa | Compounds | References |
Rattus norvegicus | Anionic trypsin-1 | 246 aa | 23.2% | 246 aa | Compounds | References |
Canis lupus familiaris | Tryptase | 275 aa | 24.8% | 270 aa | Compounds | References |
Sus scrofa | Glandular kallikrein | 246 aa | 25.6% | 250 aa | Compounds | References |
Sus scrofa | Trypsin | 231 aa | 21.1% | 246 aa | Compounds | References |
Bos taurus | Trypsin II | 247 aa | 24.8% | 246 aa | Compounds | References |
Bos taurus | Alpha-chymotrypsin | 245 aa | 22.5% | 231 aa | Compounds | References |
Rattus norvegicus | Tryptase alpha/beta-1 | 273 aa | 25.2% | 242 aa | Compounds | References |
Sus scrofa | Elastase 1 | 266 aa | 23.0% | 222 aa | Compounds | References |
Rattus norvegicus | Trypsin II | 246 aa | 22.5% | 249 aa | Compounds | References |